Biotechnology entails the use of technology and science to develop solutions for societal issues such as climate mitigation access to and the sustainability of natural resources as well as food security. Biotechnology companies can be classified into different categories based on the solutions they are attempting to offer.

The majority of biotech companies are pharmaceutical companies that manufacture medicines for humans and animals. Typically, drug development takes years and is a highly risky endeavor with a high percentage of potential drugs failing to make it from the lab to the shelves of pharmacies.

However, biotech isn't restricted to developing pharmaceuticals. many other industries can utilize the technology. Some of them include agriculture, cosmetics food and environmental technologies as well as industrial biotechnology, nutraceuticals and animal products.

Other areas of research involve the development of mRNA-based vaccines, which has been utilized in the COVID-19 pandemic, and monoclonal antibody development, which is currently being tested as an option for treating HIV. The industry is marked by high operating costs and significant funding for R&D.

This is why the majority of biotech companies are not profitable at the beginning of their development. Companies that are profitable have pipelines that are strong and they can also generate non-organic revenue. Biotech investment can be profitable but it is crucial to be aware of the risks involved. It is not uncommon that biotech stocks will rise on the news of a promising new therapy's results. These spikes can be difficult for small investors.